Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma.
Khan AB, English CW, Chen WC, Athukuri P, Bayley JC 5th, Brandt VL, Shetty A, Hadley CC, Choudhury A, Lu HC, Harmanci AO, Harmanci AS, Magill ST, Raleigh DR, Klisch TJ, Patel AJ.
Khan AB, et al. Among authors: shetty a.
Acta Neuropathol. 2023 Apr;145(4):501-503. doi: 10.1007/s00401-023-02543-7. Epub 2023 Feb 2.
Acta Neuropathol. 2023.
PMID: 36729132
Free PMC article.
No abstract available.